Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
“While no drug is without side effects, health problems associated with obesity almost certainly exceed the risks of GLP-1 agonists,” Musk said as early as Oct. 2023. GLP-1 agonists are a class of medications that can help manage Type 2 diabetes and obesity.
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
Should RFK Jr. be confirmed as HHS secretary, he will wield power over policy details that could shape the trajectory of U.S.
The world’s richest man has clashed with incoming Health and Human Services chief Robert F. Kennedy Jr. over the role weight-loss medications should play in making Americans healthier and thinner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback